Florence S Namour (Florence Namour)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Idiopathic Pulmonary Fibrosis

Tandem Mass Spectrometry

Ultra High Performance Liquid Chromatography

Top Venues

Clinical pharmacology and therapeutics

British journal of clinical pharmacology

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Amit Taneja, Garrit Jentsch, Stéphane Delage, Matthew J Randall, Bernt van den Blink, Yasmina Bauer, Florence S Namour
ISABELA studies: plasma exposure and target engagement do not explain the lack of efficacy of ziritaxestat in patients with IPF. Clinical pharmacology and therapeutics (2023)
Eric Helmer, Negin Karimian, Karen Van Assche, Ineke Seghers, Sandrine Le Tallec, Ganesh Cherala, Graham Scott, Florence S Namour
Ziritaxestat Drug-Drug Interaction with Oral Contraceptives: Role of SULT1E1 Inhibition. Clinical pharmacology and therapeutics 112 (4) (2022)
Florence S Namour, Kacey Anderson, Cara Nelson, Chantal Tasset
Filgotinib: A Clinical Pharmacology Review. Clinical pharmacokinetics 61 (6) (2022)
Florence S Namour, Liesbeth Fagard, Annegret Van der Aa, Pille Harrison, Yan Xin, Chantal Tasset
Influence of age and renal impairment on the steady state pharmacokinetics of filgotinib, a selective JAK1 inhibitor. British journal of clinical pharmacology 84 (12) (2018)